Clinical research progress on β-cell dysfunction in T2DM development in the Chinese population.
Saved in:
| Title: | Clinical research progress on β-cell dysfunction in T2DM development in the Chinese population. |
|---|---|
| Authors: | Chen Y; State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100050, China.; Diabetes Research Center of Chinese Academy of Medical Sciences, Beijing, 100050, China.; CAMS Key Laboratory of Molecular Mechanism and Target Discovery of Metabolic Disorder and Tumorigenesis, Beijing, 100050, China., Jiang Q; State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100050, China.; Diabetes Research Center of Chinese Academy of Medical Sciences, Beijing, 100050, China.; CAMS Key Laboratory of Molecular Mechanism and Target Discovery of Metabolic Disorder and Tumorigenesis, Beijing, 100050, China., Xing X; State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100050, China.; Diabetes Research Center of Chinese Academy of Medical Sciences, Beijing, 100050, China.; CAMS Key Laboratory of Molecular Mechanism and Target Discovery of Metabolic Disorder and Tumorigenesis, Beijing, 100050, China., Yuan T; Department of Endocrinology, Key Laboratory of Endocrinology of Ministry of Health, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China. t75y@sina.com., Li P; State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100050, China. lipp@imm.ac.cn.; Diabetes Research Center of Chinese Academy of Medical Sciences, Beijing, 100050, China. lipp@imm.ac.cn.; CAMS Key Laboratory of Molecular Mechanism and Target Discovery of Metabolic Disorder and Tumorigenesis, Beijing, 100050, China. lipp@imm.ac.cn. |
| Source: | Reviews in endocrine & metabolic disorders [Rev Endocr Metab Disord] 2025 Feb; Vol. 26 (1), pp. 31-53. Date of Electronic Publication: 2024 Oct 09. |
| Publication Type: | Journal Article; Review; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Springer Country of Publication: Germany NLM ID: 100940588 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-2606 (Electronic) Linking ISSN: 13899155 NLM ISO Abbreviation: Rev Endocr Metab Disord Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1573-2606 |
|---|---|
| DOI: | 10.1007/s11154-024-09914-9 |
